Show simple item record

dc.contributor.authorGavaghan, Callan
dc.contributor.authorJayasinghe, Rohan
dc.date.accessioned2019-09-11T05:25:09Z
dc.date.available2019-09-11T05:25:09Z
dc.date.issued2018
dc.identifier.issn1836-1935
dc.identifier.doi10.21767/AMJ.2018.3485
dc.identifier.urihttp://hdl.handle.net/10072/387218
dc.description.abstractBackground: The metabolic syndrome (MetSy), which is defined by the spectrum of obesity, insulin resistance and dyslipidaemia, is recognised as a major contributor to the overall risk of developing cardiovascular disease. Intermittent fasting (IF), which encompasses dieting plans with varying schedules of fasting, may be an effective method of reducing the burden of MetSy and the consequent cardiovascular events in the face of a worsening obesity epidemic in the contemporary society. Aims: Despite the widespread public interest there is a serious lack of scientific understanding of the evidence base and the safe, optimal recommendations. This has created a level of public confusion that we endeavour to address by this narrative review of the published literature. Methods: This narrative literature review summarises the current findings and suggests which regimens may be more effective and where future research in this area should be focused. Results: Although the ideal regimen for IF remains unclear, there is promising evidence that alternate day fasting or modified fasting regimens, paired with or without continuous caloric restriction, may be more effective than continuous caloric restriction alone. Conclusion: IF has been shown in the small number of human clinical trials discussed here to be an alternative to continuous caloric restriction in reducing the factors that contribute to the development of cardiovascular disease. Long-term randomised, controlled trials comparing continual caloric restriction and IF are required to objectively assess energy intake, energy expenditure, adherence, disease outcomes and metabolic factors.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherAustralasian Medical Journal
dc.relation.ispartofpagefrom426
dc.relation.ispartofpageto433
dc.relation.ispartofissue8
dc.relation.ispartofjournalAustralasian Medical Journal
dc.relation.ispartofvolume11
dc.subject.fieldofresearchClinical Sciences
dc.subject.fieldofresearchPublic Health and Health Services
dc.subject.fieldofresearchcode1103
dc.subject.fieldofresearchcode1117
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsMedicine, General & Internal
dc.subject.keywordsGeneral & Internal Medicine
dc.subject.keywordsIntermittent fasting
dc.titleIntermittent fasting for cardiovascular disease risk factor reduction: A narrative review of current evidence
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationGavaghan, C; Jayasinghe, R, Intermittent fasting for cardiovascular disease risk factor reduction: A narrative review of current evidence, Australasian Medical Journal, 2018, 11 (8), pp. 426-433
dc.date.updated2019-09-10T04:32:10Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© The Author(s) 2018. The attached file is reproduced here in accordance with the copyright policy of the publisher. For information about this journal please refer to the journal’s website or contact the author(s).
gro.hasfulltextFull Text
gro.griffith.authorJayasinghe, Rohan
gro.griffith.authorGavaghan, Callan B.


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record